Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.19 -0.25 (-1.22%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Other Non-Current Assets (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) recorded Other Non-Current Assets of $7.85 million in Q2 2026, down 17.2% from $9.47 million a year earlier and unchanged from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Starting with Q4 2010, Acadia Pharmaceuticals' Other Non-Current Assets history includes 60 quarters.

  • Annual Other Non-Current Assets has a five-year compound annual growth rate of 6.3% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Assets came in at $8.77 million in FY2024 (+52.0%), $5.77 million in FY2023 (unchanged), $5.77 million in FY2022 (unchanged) and $5.77 million in FY2021 (unchanged).
  • Quarterly Other Non-Current Assets has ranged from $5.77 million in Q3 2021 to $9.47 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Other Non-Current Assets has declined for three consecutive quarters, with growth averaging 23.7% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 64.1% in Q2 2025, against a decline of 28.9% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.85 million (Q1 2026), $7.85 million (Q4 2025) and $9.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Acadia Pharmaceuticals 3.47 Bn -4.91 Mn 279.64 Mn 11.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.40 Mn
Mar 31, 2026 11.77 Mn
Dec 31, 2025 11.74 Mn
Sep 30, 2025 12.47 Mn
Jun 30, 2025 9.47 Mn
Mar 31, 2025 8.77 Mn
Dec 31, 2024 8.77 Mn
Sep 30, 2024 8.77 Mn
Jun 30, 2024 5.77 Mn
Mar 31, 2024 5.77 Mn
Dec 31, 2023 5.77 Mn
Sep 30, 2023 5.77 Mn
Jun 30, 2023 8.12 Mn
Mar 31, 2023 5.77 Mn
Dec 31, 2022 5.77 Mn
Sep 30, 2022 5.77 Mn
Jun 30, 2022 5.77 Mn
Mar 31, 2022 5.77 Mn
Dec 31, 2021 5.77 Mn
Sep 30, 2021 5.77 Mn
API Access

Acadia Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY